Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
Jefferies Names AMEC Top China Semiconductor Equipment Pick 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
Meta, U.S. States Discuss Settlement in Teen Addiction Trial 
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
Amazon Secures 200 MW Wind Power Deals in Sweden 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Add as a preferred source on Google
DUBLIN, Ireland, April 09, 2018 -- Horizon Pharma plc (Nasdaq:HZNP) announced today that its first-quarter financial results will be released on Wednesday, May 9, 2018. Following the announcement, Horizon's management will host a live webcast at 8 a.m. Eastern Time to review the Company's financial and operating results.
The live webcast and replay may be accessed at http://ir.horizon-pharma.com. Please connect to the Company's website at least 15 minutes before the live webcast to ensure adequate time for any software download that may be needed to access the webcast.
About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter, like us on Facebook or explore career opportunities on LinkedIn.
Contacts:
Investors:
Tina Ventura
Senior Vice President,
Investor Relations
[email protected]
Ruth Venning
Executive Director,
Investor Relations
[email protected]
U.S. Media:
Geoff Curtis
Senior Vice President,
Corporate Affairs & Chief Communications Officer
[email protected]
Ireland Media:
Ray Gordon
Gordon MRM
[email protected]
